Quadrature Capital’s Precigen PGEN Stock Holding History

Quadrature Capital’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-179,359	Closed	-$694K	–	1949
2026 Q1	$694K	Buy	+179,359	New	+$736K	0.01%	682

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quadrature Capital's PGEN Position: Q2 2026 in Review

Quadrature Capital sold out of Precigen (PGEN) in Q2 2026, closing a stake of 179,359 shares — an estimated $694K sold.

Quadrature Capital first reported a position in PGEN in Q1 2026 and held it in 1 quarter. The position peaked at $694K in Q1 2026. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

Quadrature Capital reported no remaining Precigen position as of Q2 2026 after selling out during the quarter.
Quadrature Capital sold 179,359 Precigen shares in Q2 2026, an estimated $694K.
Quadrature Capital first reported a position in Precigen in Q1 2026 and held it in 1 quarter.
Quadrature Capital's Precigen position peaked at $694K in Q1 2026.
210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.